Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT Study: 12 vs 30 Months of DAPT after PCI
NCT00977938Phase 4Completed
- Sponsor
- Baim Institute for Clinical Research
- Start
- Oct 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 4, randomised, double-blind trial of clopidogrel and prasugrel in coronary artery disease (CAD), sponsored by Baim Institute for Clinical Research. Primary endpoint: Major Adverse Cardiovascular and Cerebrovascular Events at 18 months. Started Oct 2009; status: completed.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00977938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977938.